TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026
Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.
Toby A Eyre et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.